In one paragraphArticle in Chemical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
6 authors.
Guihai GanDepartment of Pharmacy, The First Affiliated Hospital of University of Science and Technology of China (USTC), Division of Life Sciences and Medicine, Hefei National Research Center for Physical Sciences at the Microscale, Department of Polymer Science and Engineering, University of Science and Technology of China Hefei Anhui Province 230026 China jmhu@ustc.edu.cn.ORCID https://orcid.org/0009-0008-2458-6276 Yuanmeng FangDepartment of Pharmacy, The First Affiliated Hospital of University of Science and Technology of China (USTC), Division of Life Sciences and Medicine, Hefei National Research Center for Physical Sciences at the Microscale, Department of Polymer Science and Engineering, University of Science and Technology of China Hefei Anhui Province 230026 China jmhu@ustc.edu.cn.ORCID https://orcid.org/0009-0005-0941-4829 Siyuan LuoDepartment of Pharmacy, The First Affiliated Hospital of University of Science and Technology of China (USTC), Division of Life Sciences and Medicine, Hefei National Research Center for Physical Sciences at the Microscale, Department of Polymer Science and Engineering, University of Science and Technology of China Hefei Anhui Province 230026 China jmhu@ustc.edu.cn.ORCID https://orcid.org/0009-0001-2301-5876 Zhiqiang ShenDepartment of Pharmacy, The First Affiliated Hospital of University of Science and Technology of China (USTC), Division of Life Sciences and Medicine, Hefei National Research Center for Physical Sciences at the Microscale, Department of Polymer Science and Engineering, University of Science and Technology of China Hefei Anhui Province 230026 China jmhu@ustc.edu.cn.ORCID https://orcid.org/0000-0002-3439-869X Yao LuDepartment of Anesthesiology, The First Affiliated Hospital of Anhui Medical University, Key Laboratory of Anesthesia and Perioperative Medicine of Anhui Higher Education Institutes, Anhui Medical University Hefei 230022 China luyao@ahmu.edu.cn.ORCID https://orcid.org/0000-0001-8116-4477 Jinming HuDepartment of Pharmacy, The First Affiliated Hospital of University of Science and Technology of China (USTC), Division of Life Sciences and Medicine, Hefei National Research Center for Physical Sciences at the Microscale, Department of Polymer Science and Engineering, University of Science and Technology of China Hefei Anhui Province 230026 China jmhu@ustc.edu.cn.ORCID https://orcid.org/0000-0002-6969-1343 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
The development of nitric oxide (NO) delivery systems with spatiotemporally controlled release is critical for achieving on-demand therapeutic effects while minimizing side effects. Although precise modulation of NO-release kinetics is highly desirable in biomedical applications, the design of single-component donors capable of controlled, stepwise release remains a significant challenge. Here, we report the first example of red-light-mediated, stepwise NO release from a single-component donor, enabled by a PdTPTBP photocatalyst
Identifiers
PMID42559440
PMCPMC13440345
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390